SAN FRANCISCO, April 01, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds IRSA Inversiones y Representaciones S.A. (NYSE:IRS) investors of the April 25, 2016 lead plaintiff deadline in the securities fraud class action lawsuit related to IRS’s improper accounting for $6.7 billion debt.
If you suffered significant losses because of your purchases of IRS between November 3, 2014 and December 30, 2015, or have information that will help our continuing investigation contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing [email protected] or visiting https://www.hbsslaw.com/cases/IRS . The lawsuit was filed in the U.S. District Court for the Central District of California and investors have until April 25, 2016 to move the court to participate as a lead plaintiff.
The class action complaint alleges that IRS and certain of its directors and executives made false and misleading statements and/or failed to disclose that: (1) IRSA’s subsidiary, Netherlands B.V. (“Dolphin”), did not adequately qualify as a Venture Capital Organization and, therefore, IBD Development Corporation Limited’s (“IDBD”) $6.7 billion net debt should be consolidated with the Company’s financial statements; (2) the impending consolidation of IDBD’s debt would violate IRSA’s Global Notes Indenture; (3) the terms of the February 2015 related party transaction between Dolphin and Inversiones Financieras Del Sur S.A.; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
Whistleblowers: Persons with non-public information regarding IRSW should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 



